BDX News and Press, Becton Dickinson and Company From 01/31/23

BD Named to Bloomberg Gender-Equality Index for 4th Consecutive Year PR Newswire Company's Ongoing Commitment to Advance Workplace Equality Shows Progress in Female Leadership and Talent Pipeline FRANKLIN LAKES, N.J. , Jan. 31, 2023 /PRNewswire/ -- BD...

Summary Yacktman's 13F equity portfolio value increased from $9.17B to $10.04B this quarter. Yacktman Asset Management increased Charles Schwab while decreasing PepsiCo, Sysco, and Weatherford International. Yacktman’s largest five stakes are at ~26% of the portfolio. ...

Summary ResMed continues to be a leading company in the industry, with multiple growth drivers ahead of its 2025 goals. But the outlook for ResMed doesn't look good, with YoY figures slowing and dividend payments possibly being interrupted. This has called its high valuation multipl...

Summary Today, VATE costs under $3 but is a bargain beneath $4. Their infrastructure business alone is worth $1. Life Sciences offers $15-$20 of embedded optionality. It's rare to uncover a single investment in the new economy that's best-in-class. To find a co...

BD Publishes 2022 Cybersecurity Annual Report PR Newswire Highlights Critical Importance of Transparency and Collaboration FRANKLIN LAKES, N.J. , Jan. 25, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical te...

Becton, Dickinson ( NYSE: BDX ) declares $0.91/share quarterly dividend , in line with previous. Forward yield 1.48% Payable March 31; for shareholders of record March 10; ex-div March 9. See BDX Dividend Scorecard, Yield Chart, & Dividend Growth. For fur...

Summary The Top Six Healthcare Products and Service companies are some of the most popular investments in the market. However, they offer varying financial profiles. To understand where opportunity may lie, I ranked the group according to various financial metrics. Read on to se...

Summary Medical devices company Becton Dickinson spun off Embecta last year. After an uneventful start, shares plunged in December on a bad earnings report. Even after the decline, I'm not sure the value proposition is clear enough to warrant buying just yet. F...

Summary In 2015, I started publishing updates regarding my dividend growth portfolio, and I keep doing so every quarter. This is part of being transparent with my readers, so they can see what I hold and its correlation with my writing. This article summarizes Q4 of 2022 and focuses...

Palm Beach, FL – January 12, 2023 – FinancialNewsMedia.com News Commentary – The drug delivery system is a device that enables the introduction of a drug in the body and improves its efficacy and safety by controlling the rate, time, and place of release of drugs ...